INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 160 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,562,355 | +13.2% | 955,005 | +37.5% | 0.01% | +8.3% |
| Q1 2023 | $9,328,975 | +305667.8% | 694,637 | +181.6% | 0.01% | +200.0% |
| Q4 2022 | $3,051 | -99.9% | 246,635 | +34.7% | 0.00% | 0.0% |
| Q3 2022 | $2,554,000 | +17.6% | 183,106 | +16.4% | 0.00% | +33.3% |
| Q2 2022 | $2,172,000 | -6.3% | 157,293 | +10.4% | 0.00% | 0.0% |
| Q1 2022 | $2,319,000 | -0.1% | 142,525 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $2,322,000 | +47.1% | 142,525 | +34.0% | 0.00% | 0.0% |
| Q3 2021 | $1,579,000 | – | 106,323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 234,375 | $23,623,000 | 22.67% |
| Boxer Capital, LLC | 600,000 | $60,474,000 | 7.47% |
| DLD Asset Management, LP | 834,600 | $84,136,000 | 5.77% |
| GREAT POINT PARTNERS LLC | 200,000 | $20,158,000 | 2.55% |
| BB BIOTECH AG | 575,719 | $58,027,000 | 1.86% |
| Elk Creek Partners, LLC | 207,657 | $20,930,000 | 1.74% |
| ALTRINSIC GLOBAL ADVISORS LLC | 277,944 | $28,014,000 | 1.34% |
| Sarissa Capital Management LP | 54,000 | $5,442,000 | 1.21% |
| QCM Cayman, Ltd. | 2,181 | $220,000 | 0.90% |
| Opus Point Partners Management, LLC | 3,534 | $356,000 | 0.78% |